Circulating upregulated miR-210 and miR-21 and downregulated miR-126 expression have shown potential as diagnostic biomarkers for CRC as they are involved in the HIF-1α/VEGF signaling pathways for colon cancer initiation [45]. The gene discussed is HIF1A; the disease is colorectal carcinoma.